Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide from the pineal gland that activates telomerase (hTERT) to extend telomere length; Thymalin is a thymic polypeptide bioregulator complex derived from calf thymus extract that modulates adaptive immunity, restores thymic function, and has demonstrated lifespan extension in controlled rodent studies — both developed within the St Petersburg bioregulator peptide research programme (Khavinson et al.).
Research reference only — all information on this page summarises peer-reviewed scientific literature and does not constitute medical advice. View full compound profiles: Epitalon · Thymalin
Mechanism Comparison
Both Epitalon and Thymalin belong to the class of "cytamine bioregulators" — peptide preparations developed by Vladimir Khavinson's group at the St Petersburg Institute of Bioregulation and Gerontology. Epitalon (Ala-Glu-Asp-Gly) is the synthetic analogue of epithalamin, a peptide originally extracted from bovine pineal glands. Its primary documented mechanism is activation of telomerase reverse transcriptase (hTERT), which extends telomere length in human somatic cells — directly addressing the telomere attrition hallmark of cellular aging. Secondary mechanisms include antioxidant activity and modulation of circadian melatonin secretion through the pineal gland. Thymalin is not a single defined peptide but a polypeptide bioregulator complex fractionated from thymic tissue extract, containing a mixture of short peptides that restore thymic peptide activity. Its primary pharmacology is immune-normalising: restoring T-lymphocyte subset ratios, enhancing NK cell activity, and normalising cytokine profiles in aged or immunocompromised models — effectively addressing the immunosenescence that accompanies aging. Where Epitalon targets cellular longevity at the chromosomal level (telomere maintenance), Thymalin targets the systemic immune competence that declines with thymic involution.
Side-by-Side Attributes
| Attribute | Epitalon | Thymalin |
|---|---|---|
| Chemical identity | Synthetic tetrapeptide (Ala-Glu-Asp-Gly) | Polypeptide bioregulator complex (thymus extract) |
| Gland of origin | Pineal gland (epiphysis) | Thymus gland |
| Molecular weight | 390.4 g/mol | Mixture (~1–10 kDa range) |
| CAS number | 307297-39-8 | Complex mixture — no single CAS |
| Primary mechanism | Telomerase (hTERT) activation; telomere elongation | Thymic immune restoration; T-lymphocyte normalisation |
| Aging hallmark targeted | Telomere attrition | Immunosenescence / thymic involution |
| Regulatory status | Investigational; research compound | Investigational; approved in Russia (as Thymalin injection) |
| Human lifespan data | Small Russian clinical trials (15+ year follow-up data) | Controlled rodent studies showing lifespan extension; human trial data |
| Stability / administration | Stable tetrapeptide; SC or intranasal | Bioregulator complex; requires injection; cold-chain storage |
Key Research Points
- 1Both Epitalon and Thymalin were central to Khavinson's 20-year prospective study of bioregulator peptides in aged populations (St Petersburg elderly cohort, 1992–2012). The study demonstrated statistically significant reductions in all-cause mortality and cardiovascular mortality in subjects receiving annual peptide bioregulator courses vs controls — one of the longest prospective bioregulator trials in gerontology.
- 2Epitalon's telomerase activation has been demonstrated in human somatic cells in vitro (Khavinson et al., Bulletin of Experimental Biology and Medicine, 2003) and in rodent lifespan models. The mechanism — hTERT activation → telomere elongation → delayed replicative senescence — directly targets the "molecular clock" theory of cellular aging.
- 3Thymalin addresses thymic involution, the age-related atrophy of the thymus gland that begins in early adulthood and leads to declining naïve T-cell output and progressive immunosenescence. By restoring thymic polypeptide activity, Thymalin aims to maintain adaptive immune competence in aged models — a complementary mechanism to Epitalon's chromosomal-level effects.
- 4The combination of pineal-derived (Epitalon) and thymic-derived (Thymalin) bioregulators has been studied in the same research framework as complementary anti-aging approaches: Epitalon addressing cellular senescence at the telomere level and Thymalin restoring the immune surveillance capacity that declines with age. Khavinson's group published data suggesting additive effects when both bioregulators are used together in aging protocols.
- 5Thymalin is distinct from Thymulin (facteur thymique sérique, FTS) — a well-characterised zinc-dependent thymic hormone with a defined 9-amino-acid sequence (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn). Thymalin is a multi-peptide thymus extract, while Thymulin is a single defined peptide hormone. Researchers should verify which compound is intended in protocol design.
Frequently Asked Questions
What is the difference between Epitalon and Thymalin?
Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide analogue of the pineal gland peptide epithalamin, with a primary mechanism of telomerase (hTERT) activation and telomere elongation in somatic cells. Thymalin is a polypeptide bioregulator complex derived from calf thymus extract, with primary mechanisms of immune restoration — normalising T-lymphocyte subsets, enhancing NK cell activity, and addressing thymic involution-associated immunosenescence. Both were developed by Khavinson's group in St Petersburg and studied in the same 20-year prospective cohort, but they target different molecular hallmarks of aging: telomere attrition (Epitalon) versus immunosenescence (Thymalin).
Is Thymalin the same as Thymulin?
No — these are distinct compounds. Thymalin is a polypeptide bioregulator complex isolated from thymic tissue by fractionation, containing a mixture of short peptides that restore thymic functional activity. It was developed by Khavinson's research group and is registered as a pharmaceutical in Russia. Thymulin (facteur thymique sérique, FTS) is a single, well-characterised zinc-dependent thymic hormone: a 9-amino-acid peptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) that requires zinc for biological activity. Thymulin is produced by thymic epithelial cells and declines significantly with age. The two share thymic origin and immune-modulating activity but differ fundamentally in chemical identity.
What evidence exists for Epitalon and Thymalin lifespan extension?
The most cited evidence comes from Khavinson's controlled rodent studies and a 20-year prospective cohort study in aged humans in St Petersburg (published across multiple papers, 1992–2012). Rodent studies with Epitalon showed 12–33% increases in mean lifespan in multiple mouse and rat strains alongside reduced tumour incidence. Rodent studies with Thymalin demonstrated similar lifespan extensions and improved immune parameters. The human prospective study reported significantly reduced all-cause and cardiovascular mortality in the bioregulator-treated group versus control over 15+ years. These findings have not been independently replicated in large randomised controlled trials under Western regulatory frameworks (FDA/EMA), which remains a key limitation of the evidence base.
Deep Dive
For extended mechanism analysis, trial data, and regulatory context, see the full research article:
Epitalon and Telomerase: The Longevity Research Behind the Pineal Tetrapeptide →Full compound profile
Epitalon
Full compound profile
Thymalin